Positive top-line findings announced for congenital obesity drug – Healio

Positive top-line findings announced for congenital obesity drug HealioRhythm Pharmaceuticals announced positive results from two phase 3 clinical trials evaluating setmelanotide, a melanocortin-4 receptor agonist for the …

From http://besthealthnews.com/2019/08/positive-top-line-findings-announced-for-congenital-obesity-drug-healio/?utm_source=rss&utm_medium=rss&utm_campaign=positive-top-line-findings-announced-for-congenital-obesity-drug-healio

from
https://healthnews010.wordpress.com/2019/08/20/positive-top-line-findings-announced-for-congenital-obesity-drug-healio/